Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 715

1.

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M, Sherman M.

Gut. 2001 Feb;48(2):251-9.

2.

[Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis].

Bolondi L, Gaiani S, Casali A, Serra C, Piscaglia F.

Radiol Med. 1997 Jul-Aug;94(1-2):4-7. Italian.

PMID:
9424649
3.

Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.

Qian MY, Yuwei J R, Angus P, Schelleman T, Johnson L, Gow P.

J Gastroenterol Hepatol. 2010 May;25(5):951-6. doi: 10.1111/j.1440-1746.2009.06203.x.

PMID:
20546449
4.

Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.

Nouso K, Tanaka H, Uematsu S, Shiraga K, Okamoto R, Onishi H, Nakamura S, Kobayashi Y, Araki Y, Aoki N, Shiratori Y.

J Gastroenterol Hepatol. 2008 Mar;23(3):437-44. Epub 2007 Aug 6.

PMID:
17683496
5.

Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.

Patel D, Terrault NA, Yao FY, Bass NM, Ladabaum U.

Clin Gastroenterol Hepatol. 2005 Jan;3(1):75-84.

PMID:
15645408
6.

Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.

Arguedas MR, Chen VK, Eloubeidi MA, Fallon MB.

Am J Gastroenterol. 2003 Mar;98(3):679-90.

PMID:
12650806
7.

Efficacy of a surveillance program for early detection of hepatocellular carcinoma.

Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E.

Cancer. 1996 Sep 1;78(5):977-85.

8.

[Evaluation of hepatic resection for hepatocellular carcinoma on cirrhotic livers].

Silva M, Mattos AA, Fontes PR, Waechter FL, Pereira-Lima L.

Arq Gastroenterol. 2008 Apr-Jun;45(2):99-105. Portuguese.

9.

Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?

Trevisani F, Santi V, Gramenzi A, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M; Italian Liver Cancer Group.

Am J Gastroenterol. 2007 Nov;102(11):2448-57; quiz 2458. Epub 2007 Jul 7.

PMID:
17617210
10.
11.

Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.

Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, Jackson S, Ryder S, Price A, Stein K.

Health Technol Assess. 2007 Sep;11(34):1-206. Review.

12.

Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.

Macías Rodríguez MA, Rendón Unceta P, Tejada Cabrera M, Infante Hernández JM, Correro Aguilar F, Díaz García F, Benítez Rodríguez E, Mangas Rojas A, Martín Herrera L.

Rev Esp Enferm Dig. 2000 Jul;92(7):458-69. English, Spanish.

PMID:
11026763
13.

[Screening for hepatocarcinoma in a cohort with cirrhosis mainly of alcoholic origin].

Henrion J, Libon E, De Maeght S, Deltenre P, Schapira M, Ghilain JM, Maisin JM, Heller FR.

Gastroenterol Clin Biol. 2003 May;27(5):534-9. French.

14.

Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients.

Sangiovanni A, Colombo E, Radaelli F, Bortoli A, Bovo G, Casiraghi MA, Ceriani R, Roffi L, Redaelli A, Rossini A, Spinzi G, Minoli G.

Am J Gastroenterol. 2001 May;96(5):1575-80.

PMID:
11374702
15.

Hepatocellular carcinoma in liver cirrhosis. A prospective study.

Imberti D, Fornari F, Sbolli G, Buscarini E, Squassante L, Buscarini L.

Scand J Gastroenterol. 1993 Jun;28(6):540-4.

PMID:
7686686
16.

Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis.

Velázquez RF, Rodríguez M, Navascués CA, Linares A, Pérez R, Sotorríos NG, Martínez I, Rodrigo L.

Hepatology. 2003 Mar;37(3):520-7.

PMID:
12601348
17.

Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.

Ando E, Kuromatsu R, Tanaka M, Takada A, Fukushima N, Sumie S, Nagaoka S, Akiyoshi J, Inoue K, Torimura T, Kumashiro R, Ueno T, Sata M.

J Clin Gastroenterol. 2006 Nov-Dec;40(10):942-8.

PMID:
17063116
18.

Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.

Amarapurkar D, Han KH, Chan HL, Ueno Y; Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma.

J Gastroenterol Hepatol. 2009 Jun;24(6):955-61. doi: 10.1111/j.1440-1746.2009.05805.x. Epub 2009 Mar 11.

PMID:
19383082
19.

Does the choice of treatment influence survival of patients with small hepatocellular carcinoma in compensated cirrhosis?

Farinati F, Gianni S, Marin G, Fagiuoli S, Rinaldi M, Naccarato R.

Eur J Gastroenterol Hepatol. 2001 Oct;13(10):1217-24.

PMID:
11711779
20.

Management of the single liver nodule in a cirrhotic patient: a decision analysis model.

El-Serag HB, Mallat DB, Rabeneck L.

J Clin Gastroenterol. 2005 Feb;39(2):152-9.

PMID:
15681913
Items per page

Supplemental Content

Write to the Help Desk